A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

Lumbosacral Radicular Pain Clinical Trial

Official title:
An Open-label, Single-arm Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 Administered by Epidural Injection in Subjects With Lumbosacral Radiculopathy

Status Completed

Clinical Trial Summary

This is an open-label, single-arm, repeat dose study to characterize the pharmacodynamics and safety/tolerability of SP-102 administered by epidural injection.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Lumbosacral Radicular Pain

Clinical Trial Details

NCT number	NCT03613662
Study type	Interventional
Source	Scilex Pharmaceuticals, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	July 13, 2018
Completion date	March 15, 2019

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03057197` - The Influence of Needle-insertion Depth on Successful Epidurogram and Clinical Outcome in Caudal Epidural Injections	N/A
Completed	`NCT02867046` - The Incidence of the Intravascular Injection During S1 Transforaminal Epidural Steroid Injection in Two Approaches: Medial vs Lateral in Anteroposterior View	N/A
Completed	`NCT01926470` - The Incidence of the Intravascular Injection During S1 Transforaminal Epidural Steroid Injection in Two Approaches: Anteroposterior Versus Oblique	N/A
Completed	`NCT03372161` - Corticosteroid Lumbar Epidural Analgesia for Radiculopathy	Phase 3